SCHEMBL29478288

SCHEMBL29478288

O=C1COc2cc(NCc3cccc(C(=O)Nc4cccnc4)c3)c(Cl)cc2N1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 1.00
▸ CYP19A1 P11511 5/20 1.00
▸ CYP1A2 P05177 4/20 1.00
▸ CYP2C9 P11712 3/20 0.83
▸ CYP2C19 P33261 2/20 0.83
▸ CYP2D6 P10635 1/20 0.55
▸ ROCK2 O75116 1/20 0.45
▸ PARP1 P09874 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CHEK1 O14757 1/20 0.43
▸ CSF1R P07333 4/20 0.42
▸ NSD2 O96028 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ CLK2 P49760 1/20 0.41
▸ CLK3 P49761 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18770367 1.00 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL29478289 0.91 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL18770357 0.91 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL29478290 0.86 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL18770307 0.86 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL18770362 0.80 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL29478294 0.80 CYP3A4 (1.00) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL18770334 0.74 CYP3A4 (0.75) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL14073571 0.72 ALDH1A1 (0.63) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19
SCHEMBL14073783 0.72 CYP3A4 (0.70) CYP3A4CYP19A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP claimed
CN-108779085-B Pharmacophores, compounds and methods having application in the treatment of cancer by inhibition of CYP17a1 and CYP19a1 马古苏托科技大学 2022-03-22 — — CN claimed
Send feedback